Cowen’s Pharma Outsourcing Team has prepared a short report that provides a snapshot of industry valuations and M&A activity in Pharma Outsourcing for the first quarter of 2021:
The segment is in high demand by both financial investors and strategic buyers. Despite COVID-19 and rising stock prices, we observe attractive valuations and stable sales forecasts by market participants.
With the leading Health Care equity capital markets franchise and 15 successfully completed M&A Transactions in 2020, Cowen continues to be extremely active in the Health Care sector.
Contact
Similar Insights
